Supplementation with a powdered blend of PUFAs normalizes DHA and AA levels in patients with PKU

Molecular Genetics and Metabolism

Volumn 109, Issue 2, 2013, Pages 121-124

  Jans, Judith J ^a   de Sain van der Velden, Monique G M ^a   van Hasselt, Peter M ^a   van den Hurk, Dorine T A M ^b   Vaz, Frederic M ^c   Visser, Gepke ^a   Verhoeven Duif, Nanda M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Arachidonic acid; Docosahexaenoic acid; Fish oil; KeyOmega; Phenylketonuria

Indexed keywords

ARACHIDONIC ACID; DOCOSAHEXAENOIC ACID; FATTY ACID; FISH OIL; POLYUNSATURATED FATTY ACID;

ADOLESCENT; ADULT; ARTICLE; CHILD; CONTROLLED STUDY; DIET SUPPLEMENTATION; ERYTHROCYTE LEVEL; FATTY ACID BLOOD LEVEL; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; PHENYLKETONURIA; POWDER; PRESCHOOL CHILD; PRIORITY JOURNAL; REFERENCE VALUE; SCHOOL CHILD;

ADMINISTRATION, ORAL; ADOLESCENT; ARACHIDONIC ACID; CHILD; CHILD, PRESCHOOL; DIETARY SUPPLEMENTS; DOCOSAHEXAENOIC ACIDS; FEMALE; FISH OILS; HUMANS; INFANT; MALE; PHENYLKETONURIAS; POWDERS; RETROSPECTIVE STUDIES;

EID: 84878517289     PISSN: 10967192     EISSN: 10967206     Source Type: Journal    
DOI: 10.1016/j.ymgme.2013.03.006     Document Type: Article

References (19)

1. Folling A. Uber ausscheidung von phenylbrenztraubensaure in den harn als stoffwechselanomalie in verbindung mit imbezillatat. Hoppe-Seyler's Z. Physiol. Chem. 1934, 227:169-176.
2. Scriver C.R., Kaufman S., Eisensmith R.C., Woo S.L.C. The hyperphenylalaninemias. The Metabolic and Molecular Basis of Inherited Disease 1998, 1015-1075. McGraw-Hill, New York. C.R. Scriver, A.L. Beaudet, W.S. Sly, D. Valle (Eds.).
3. Erlandsen H., Stevens R.C. The structural basis of phenylketonuria. Mol. Genet. Metab. 1999, 68(2):103-125.
4. Enns G.M., et al. Suboptimal outcomes in patients with PKU treated early with diet alone: revisiting the evidence. Mol. Genet. Metab. 2010, 101(2-3):99-109.
5. DeRoche K., Welsh M. Twenty-five years of research on neurocognitive outcomes in early-treated phenylketonuria: intelligence and executive function. Dev. Neuropsychol. 2008, 33(4):474-504.
6. Galli C., et al. Reduced plasma C-20 and C-22 polyunsaturated fatty acids in children with phenylketonuria during dietary intervention. J. Pediatr. 1991, 119(4):562-567.
7. Giovannini M., et al. Lipid status and fatty acid metabolism in phenylketonuria. J. Inherit. Metab. Dis. 1995, 18(3):265-272.
8. Martinez M. Tissue levels of polyunsaturated fatty acids during early human development. J. Pediatr. 1992, 120(4 Pt 2):S129-S138.
9. Moseley K., Koch R., Moser A.B. Lipid status and long-chain polyunsaturated fatty acid concentrations in adults and adolescents with phenylketonuria on phenylalanine-restricted diet. J. Inherit. Metab. Dis. 2002, 25(1):56-64.
10. Infante J.P., Huszagh V.A. Impaired arachidonic (20:4n-6) and docosahexaenoic (22:6n-3) acid synthesis by phenylalanine metabolites as etiological factors in the neuropathology of phenylketonuria. Mol. Genet. Metab. 2001, 72(3):185-198.
11. Agostoni C., et al. A randomized trial of long-chain polyunsaturated fatty acid supplementation in infants with phenylketonuria. Dev. Med. Child Neurol. 2006, 48(3):207-212.
12. Agostoni C., et al. Biochemical effects of supplemented long-chain polyunsaturated fatty acids in hyperphenylalaninemia. Prostaglandins Leukot. Essent. Fat. Acids 2001, 64(2):111-115.
13. Agostoni C., et al. Effects of long-chain polyunsaturated fatty acid supplementation on fatty acid status and visual function in treated children with hyperphenylalaninemia. J. Pediatr. 2000, 137(4):504-509.
14. Beblo S., et al. Fish oil supplementation improves visual evoked potentials in children with phenylketonuria. Neurology 2001, 57(8):1488-1491.
15. Beblo S., et al. Effect of fish oil supplementation on fatty acid status, coordination, and fine motor skills in children with phenylketonuria. J. Pediatr. 2007, 150(5):479-484.
16. Agostoni C., et al. The effects of n-3 and n-6 polyunsaturated fatty acids on plasma lipids and fatty acids of treated phenylketonuric children. Prostaglandins Leukot. Essent. Fat. Acids 1995, 53(6):401-404.
17. Khairallah R.J., et al. Dietary supplementation with docosahexaenoic acid, but not eicosapentaenoic acid, dramatically alters cardiac mitochondrial phospholipid fatty acid composition and prevents permeability transition. Biochim. Biophys. Acta 1797, (8):1555-1562.
18. Fokkema M.R., et al. Assessment of essential fatty acid and omega3-fatty acid status by measurement of erythrocyte 20:3omega9 (Mead acid), 22:5omega6/20:4omega6 and 22:5omega6/22:6omega3. Prostaglandins Leukot. Essent. Fat. Acids 2002, 67(5):345-356.
19. Makrides M., et al. Fatty acid composition of brain, retina, and erythrocytes in breast- and formula-fed infants. Am. J. Clin. Nutr. 1994, 60(2):189-194.